Non-Muscle Invasive Bladder Neoplasms Clinical Trials

10 clinical trials for Non-Muscle Invasive Bladder Neoplasms across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer — RECRUITING · PHASE3
• A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States — RECRUITING
• A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer — RECRUITING · PHASE3
• A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011) — RECRUITING · PHASE2
• Study on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent TURBK. — RECRUITING
• A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer — ACTIVE_NOT_RECRUITING · PHASE1
• Study of Erdafitinib Intravesical Delivery System for Localized Bladder Cancer — ACTIVE_NOT_RECRUITING · PHASE1
• A Study of TAR-200 Versus Intravesical Chemotherapy in Participants With Recurrent High-Risk Non-Muscle-Invasive Bladder Cancer (HR-NMIBC) After Bacillus Calmette-Guérin (BCG) — ACTIVE_NOT_RECRUITING · PHASE3
• Pre-Approval Expanded Access Study for TAR-200 Treating Physician Use — OTHER
• BladMetrix Urine Test for Monitoring Recurrence in Non-Muscle Invasive Bladder Cancer — ACTIVE_NOT_RECRUITING

Refine this search